# Multiscale fusion network drives the repurposing of anticancer drugs

**Authors:** Zhaoman Wan, Nan Jiang, Mingming Su, Xinlei Zhang, Yang Cao, Aiping Wu, Peng Zhang, Taijiao Jiang

PMC · DOI: 10.1002/ctm2.1745 · Clinical and Translational Medicine · 2024-06-25

## Full-text entities

- **Genes:** PIK3CD (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta) [NCBI Gene 5293] {aka APDS, IMD14, IMD14A, IMD14B, P110DELTA, PI3K}, IGF1R (insulin like growth factor 1 receptor) [NCBI Gene 3480] {aka CD221, IGFIR, IGFR, JTK13}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}
- **Diseases:** Cancer (MESH:D009369), DSNs (MESH:D000081015)
- **Chemicals:** OSU-03012 (MESH:C500894), Linsitinib (MESH:C551528), GSK1904529A (MESH:C000607695), BX-912 (-), ADP (MESH:D000244), NVP-ADW742 (MESH:C502355), BMS-754807 (MESH:C545990), BMS-536924 (MESH:C504983)
- **Cell lines:** S2 — Drosophila melanogaster (Fruit fly), Spontaneously immortalized cell line (CVCL_Z232)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11199060/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11199060/full.md

## References

10 references — full list in the complete paper: https://tomesphere.com/paper/PMC11199060/full.md

---
Source: https://tomesphere.com/paper/PMC11199060